It may be tempting to pick up some Egalet Corporation (EGLT) stock now that the price has dropped over 75% in the last year, but be wary of catching knives which may still be falling. Much of Egalets apparent value is reliant on its Guardian Technology proving itself as a credible abuse-deterrent technology. Egalet stock should remain stagnant in the near future, and I advise to keep an eye on it and re-evaluate in mid-to-late 2018.
Opioid abuse, including the prescription drugs oxycodone, hydrocodone, and others, has risen exponentially in the last decade. Drug overdoses were the leading cause of accidental death in the United States in 2015, with prescription opioid deaths making up roughly 40% of these. As the problem grows worse, more and more companies are creating abuse-deterrent technology platforms to attempt to curb the epidemic. Egalet Corporation is focused on developing abuse-deterrent formulations of opioids using its proprietary Guardian Technology. The Guardian Technology platform is designed to make pills more resistant to physical and chemical manipulation, but Egalet's first approved product utilizing Guardian Technology, Arymo ER, did not receive all abuse-deterrent designations for which they were hoping. This could lead to a very slow stock price recovery for Egalet as much of their pipeline is reliant on Guardian Technology, which now seems like it will not be able to stand out in a crowded market.
The companys stock has been decimated in the last year due to labeling problems of its most recently approved drug, Arymo ER. Though gaining FDA approval of Arymo ER early this year, Egalet was not able to secure the coveted intranasal or oral abuse-deterrent labels. The FDA has been fairly relaxed regarding Arymo ER abuse-deterrent marketing material, but the only abuse-deterrent label granted was deterrence against intravenous use. The FDAs relaxed oversight of marketing material may be indicative of anything helps attitude in the fight against opioid abuse. While this may help Egalet market Arymo ER, there are still many problems associated with marketing a similar product in a crowded market.
Egalet has two other approved products which it is currently marketing, SPRIX Nasal Spray and Oxyado. SPRIX nasal spray is an NSAID (Nonsteroidal Anti-Inflammatory Drug) targeted at short-term (up to 5 days) pain management for moderate to severe pain which requires analgesia at the opioid level. SPRIX, which accounts for ~75% of Egalets sale, may face competition beginning in 2018 from generics as its patent protection runs out. The other approved product, Oxyado, is an IR oxycodone pill aimed designed to discourage against nasal and intravenous abuse. Egalet recently submitted approval for higher dose Oxyado (10 mg and 15 mg) which could help boost sales in 2H17. Revenues have been growing steadily for these two products, seeing double digit percentage growth quarter over quarter for the past year.
Guardian Technology is Egalets proprietary technology used to create abuse-deterrent forms of opioid pills. Apart from SPRIX nasal spray and Oxyado, all Egalets approved and pipeline products rely on Guardian Technology being accepted by the healthcare field as a viable abuse-deterrent technology. Guardian Technology takes advantage of injection molding a polymer matrix to create a physically hard and difficult to manipulate pill. The technology also resists chemical manipulation and API extraction by turning into a viscous hydrogel on contact with liquids. This allowed Arymo ER to secure an intravenous abuse-deterrent label.
It is important to note that Guardian Technology does not actually alter the API of the drug, but is a way to make it more difficult to abuse. The problem with Arymo ER and other abuse deterrent opioids on the market is that they are not effective in deterring against the most common way prescription opioids are abused orally.
During a recent conversation I had with an abuse counselor, he described drug addicts as some of the smartest, most clever people he knew. This conversation got me thinking about the innovation needed to curb the opioid abuse crisis in the United States. Yes, Guardian Technology will make it more difficult for patients to misuse prescription drugs. Yes, Guardian Technology is a step in the right direction. No, Guardian Technology should not be considered a game-changer in the fight against oral and nasal opioid abuse.
Figure 1. Orange Arrows Represent Use of Guardian Technology.
To make matters worse, the abuse-deterrent opioid market is crowded and growing more crowded rapidly. Many of the players in this field utilize abuse-deterrent mechanisms very similar to Egalets Guardian Technology (MorphaBond ER, RoxyBond, etc.). Arymo ER only securing the intravenous abuse-deterrent label greatly hindered its chance to set itself apart from the other players in the market. The FDAs comprehensive action plan to reduce opioid misuse and abuse has a provision to expand abuse-deterrent formulations (ADFSs) to discourage abuse - which should encourage even more players to enter the market.
While the fundamentals arent looking great, Egalets technical indicators imply a bounce may be coming soon. The Relative Strength Index (RSI) has been hovering in the low 30s for the last few weeks indicating oversold, and the Moving Average Convergence Divergence (MACD) seems to be crossing the signal line, indicating potential bullish momentum.
Financially speaking, Egalet is in a decent position. Net Product sales increased from $2.5 million in 1Q16 to $5.5 million in 1Q17 while net loss increased from $18.5 million to $25.4 million in the same timeframe. Arymo ER sales may rely heavily on how well product is marketed. The company has a relatively high cash burn rate, but management has expressed confidence the company has enough cash, cash equivalents, and marketable securities to last until at least June 30, 2018. The company will continue to have a high cash burn rate for the foreseeable future as it continues R&D and marketing efforts.
This stock may be a buy if you are looking to sell on any bounce in stock price. Shorting does not seem logical at this point due to the stock losing ~75% of value in under a year, but may be a good move on a substantial bounce. Overall, the risk/reward is currently not in a good enough place to establish a position either way. I would suggest keeping an eye on this ticker and establishing a contrarian position on any big move either way. Short-term, this stock may be a good buy due to a possible technical bounce.
Yes, Guardian Technology discourages abuse by making the API less accessible and more difficult to alter, but to what extent? Egalet and their proprietary Guardian Technology are obviously improvements over the large number of opioids being prescribed with no abuse-deterrent properties whatsoever. The problem is whether Guardian Technology is a game-changing innovation or small step in the right direction which could soon be overshadowed by innovations of other companies. I lean toward the latter due to the fight against opioid abuse epidemic being such a potentially profitable market. Long-term, I do not believe Egalets Guardian Technology to be the solution for the opioid crisis taking place.
Overall, while Egalet Corporation may seem like a good buy at the current price, there is still room for further falling and the possibility the company may never be profitable. The long road to profitability for Egalet, coupled with the fact Guardian Technology is not a particularly game-changing technology, leads me to recommend avoiding this stock for now. There are better places to put your money which offer a much better risk/reward ratio. If you do feel the urge to invest in this company, I would encourage you to wait until at least August 9th to better evaluate after the conference call and Arymo ER sales data.
Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.
Go here to read the rest:
- Technology Will Not Save Us - The New York Times - May 2nd, 2020
- Amid a new technology normal, gaps and gratitude for the devices that sustain us - Citizen Times - May 2nd, 2020
- COVID-19 and Technology: Commonly Used Terms - EFF - May 2nd, 2020
- Salon turns to dry fog technology to kill coronavirus ahead of reopening - FOX 31 Denver - May 2nd, 2020
- A brief history of video and technology in baseball, and how it helped teams steal signs - The Boston Globe - May 2nd, 2020
- How South Korea has used tech to successfully contain COVID-19 - Business Insider - Business Insider - May 2nd, 2020
- AI proven to be invaluable technology during pandemic - Khaleej Times - May 2nd, 2020
- The Use Of Technology And Future Of Work Has Changed Because Of COVID-19 - caribbeannationalweekly.com - May 2nd, 2020
- COVID-19 Impact on the Airport Operations Market by Technology and Region - Global Forecast to 2025 - ResearchAndMarkets.com - Yahoo Finance - May 2nd, 2020
- Apple must expand its COVID tracing technology into large scale testing - AppleInsider - May 2nd, 2020
- A 'pandemic drone' and other technology could help limit the spread of coronavirus and ease restrictions sooner, but at what cost? - ABC News - May 2nd, 2020
- Highlights from Hegeman: Getting rural Missouri the technology it needs - The Maryville Forum - May 2nd, 2020
- 15-year-olds life mission preserved through foundation providing technology to children in need - NJ.com - May 2nd, 2020
- The US already has the technology to test millions of people a day - MIT Technology Review - May 2nd, 2020
- Electric Car BYD Han To Have More Range With New Battery Technology - Fossbytes - May 2nd, 2020
- The neuroscience of loneliness and how technology is helping us - The Next Web - May 2nd, 2020
- Stimulus checks and other coronavirus relief hindered by dated technology and rocky government rollout - SF Gate - April 23rd, 2020
- Australias Fire Season Ends, and Researchers Look to the Next One - The New York Times - April 23rd, 2020
- US lawmaker says any COVID-19 contact tracing technology should be voluntary and limited - Gadgets Now - April 23rd, 2020
- Summerside convention brings new technology to the field - The Guardian - April 23rd, 2020
- 'Alexa turn on the lights;' how to add smart technology to your home - SW News Media - April 18th, 2020
- How Las Cruces Public Schools is providing technology to 1 in 5 students who need it - KVIA El Paso - April 18th, 2020
- China's strategy to reorient US tech companies is exposed what next? | TheHill - The Hill - April 18th, 2020
- How China used technology to combat COVID-19 and tighten its grip on citizens - Amnesty International - April 18th, 2020
- The importance of technology in banking during a crisis | VOX, CEPR Policy Portal - voxeu.org - April 18th, 2020
- Lux Communities leaning on technology amidst coronavirus pandemic - INFORUM - April 18th, 2020
- Is COVID-19 the push businesses need to fast-track technology adoption? - ZDNet - April 18th, 2020
- Doctor calls technology 'instrumental' in tracking the spread of COVID-19 - WBAY - April 18th, 2020
- The neuroscience of loneliness and how technology is helping us - The Conversation UK - April 18th, 2020
- Gov. Evers Signs Bill Expanding Access to Standing Technology - WEAU - April 18th, 2020
- QQQX: Technology And 'High Yield' To Beat The Markets After We Beat COVID-19 - Seeking Alpha - April 18th, 2020
- I Think It Could Be A Game Changer | Frederick Company Develops Technology To Disinfect N95 Masks - CBS Baltimore - April 18th, 2020
- Mayor of London backed tech start-up used to make 'deep fakes' - Telegraph.co.uk - April 18th, 2020
- The expansion of mass surveillance to stop coronavirus should worry us all - The Guardian - April 18th, 2020
- While We've Been in Lockdown, Solar Cell Technology Has Smashed Three Big Records - ScienceAlert - April 18th, 2020
- How new technology in Data Science is impacting the life of Data Scientists - YourStory - April 18th, 2020
- Four technologies Japan and the US should team on to counter China - C4ISRNet - April 18th, 2020
- Activist investor Starboard, which has track record of big returns in tech, finds its next target - CNBC - April 18th, 2020
- Sheriff Robert L. Langley, Jr. Reports License Plate Reader Technology Crucial to Discovery of Two Vehicles Reported Stolen - HamletHub - April 18th, 2020
- Coronavirus Contact Tracing: Apple and Google Team Up to Enable Virus Tracking - The New York Times - April 18th, 2020
- 'We are all interconnected': Coronavirus is reshaping our relationship with technology - Sydney Morning Herald - April 18th, 2020
- Nation-building through engineering and technology education - The Star Online - April 18th, 2020
- How you and your technology can help fight Covid-19 - The Irish Times - April 18th, 2020
- InteliCare seeks to bring its AI-based aged care monitoring technology to the ASX - Small Caps - April 18th, 2020
- Artificial Intelligence and the environmental crisis: 'Can technology really save the world?', asks Tayside expert - The Courier - April 18th, 2020
- More than 20,000 computers loaned to students to learn from home - Business in Vancouver - April 18th, 2020
- Have we allowed technology to become another family member? - Daily Monitor - April 18th, 2020
- Technology - Wikipedia - April 11th, 2020
- Tech 24 - Hacking the Covid-19 crisis: The role of technology - FRANCE 24 - April 11th, 2020
- National Geographic's Technology Comes to TC Williams - The Zebra - April 11th, 2020
- Religious leaders are using technology to connect with congregations during Holy Week - Long Beach Post - April 11th, 2020
- How a 5G Coronavirus Conspiracy Theory Fueled Arson and Harassment in Britain - The New York Times - April 11th, 2020
- Using technology to celebrate the holiday | Pandemic 2020 - Barre Montpelier Times Argus - April 11th, 2020
- The technology Utah is using to track the coronavirus - ABC 4 - April 11th, 2020
- Technology-Enabled Mission Command: Keeping up with the (John Paul) Joneses - War on the Rocks - April 11th, 2020
- Realtors Use Technology To Connect With Clients Amid COVID-19 - KVRR - April 11th, 2020
- David Basulto Discusses Archdaily, Technology and Design Thinking in Inspiring Design Podcast - ArchDaily - April 11th, 2020
- Specialization, technology and culture erode traditions, discourage participation - The Herald Bulletin - April 11th, 2020
- Coronavirus: How technology and apps could allow the UK to leave lockdown but impose new restrictions of their own - The Independent - April 11th, 2020
- Coronavirus could finally unleash innovative promise of 21st century technology - Washington Examiner - April 11th, 2020
- Rabbis allowing Zoom, technology on Passover during quarantine - MyNorthwest.com - April 11th, 2020
- Mixed Reality Technologies To Reshape The Workplace Of The Next Decade - Forbes - April 11th, 2020
- How Technology Has Already Begun Using Your Biometric Data - And Why it's Trustworthy - Analytics Insight - April 11th, 2020
- Rhode Island's 1950s Technology is Slowing Processing and Payment of Unemployment Claims - GoLocalProv - April 11th, 2020
- Department of Energy Announces $38 Million to Support Hydrokinetic Turbine Technology Development - Energy.gov - April 11th, 2020
- Harvard University Information Technology helps shift to online - Harvard Gazette - April 11th, 2020
- Global Terminates MOU with World Innovation Technologies Other OTC:PSYC - GlobeNewswire - April 11th, 2020
- Is Progress In Autonomous Technology Gated By Research In Animal Communication? - Forbes - April 11th, 2020
- 'Iron lung' backed by Stephen Hawking's family to be trialled on Covid-19 patients - Telegraph.co.uk - April 11th, 2020
- Etihad to trial technology designed to identify passengers with symptoms of illness - Japan Today - April 11th, 2020
- For NYC students without technology: Whats in supplemental learning packet? - SILive.com - March 28th, 2020
- Reusing N95 masks in coronavirus pandemic possible with this technology - Fox Business - March 28th, 2020
- What COVID-19 tells us about technology and human behaviour - RTE.ie - March 28th, 2020
- 31 Technology Job Positions Hiring During the COVID-19 Crisis - Dice Insights - March 28th, 2020
- New Research and Technology Ministry Consortium to Assist Covid-19 Task Force - Jakarta Globe - March 28th, 2020
- Captains using technology to bond with teammates during pause - NHL.com - March 28th, 2020
- How Alternative Dispute Resolution and Technology Can Keep Your Cases Moving in the Face of Court Closures - JD Supra - March 28th, 2020
- The history of technology is about to change radically. India must seize the moment. - YourStory - March 28th, 2020
- Dell Technologies World 2020 Rescheduled To This Fall - CRN: Technology news for channel partners and solution providers - March 28th, 2020
- Office Movers Now Come Strapped With Tracking Technologies - Bisnow - March 28th, 2020